Transforming Veterinary
Cell Therapy Treatment
We Specialize in Safe, Natural Treatments that Promote Healing, Reduce Recovery Time, and Relieve Pain
Features of MONOcells VET®
MONOcells VET® is a simple, single use disposable that concentrates PBMC using a unique filter-based technology. As blood flowsthrough the MONOcells VET® system, peripheral blood mononuclear cells (PBMC) are selectively captured on the surface of the filter and then back-flushed into a smaller volume, creating a PBMC concentrate. The MONOcells VET® system has several advantages over other techniques:
No centrifuge or power supply required
• As easy to use in the field as it is in the clinic
• Gentle gravity filtration is easy on cells and platelets, creating a high-quality concentrate that is rich in healing and growth factors
• Cost effective and efficient
• Natural cell therapy to promote healing
• Minimally invasive
• Reduces the risk of adverse reactions by the patient's own blood
• Same day procedure
• Can be used alone or in conjunction with other treatments, depending on the patient's needs
Indications for Veterinary Use
Osteoarthritis
Tendon and Ligament tears
Bone injuries
Muscle tears and strains
Cartilage damage
Joint injuries
Wound Healing
MONOcells VET concentrates PBMC
MONOcellsVET preferentially captures and concentrates PBMC
Injection of the resulting MONOcellsVET harvest into the injury site induces M2 polarization
The harvested MONOcellsVET solution encourages healing
MONOcellsVET isolates and enriches PBMCs, delivering a concentrated suspension of regenerative immune cells for targeted healing.
Macrophage Polarization
Tissues where macrophages remain activated in the inflammatory M1 phenotype and do not switch into the anti-inflammatory and regenerative M2 phenotype resulting in Chronic Inflammation
Anti-inflammatory macrophages (M2) may originate from a new wave of monocytes entering into tissues during the resolution of inflammation
A new wave of monocytes entering into tissue polarize macrophage in M2 phenotype
PBMC induce M1 to M2 polarization
M1 to M2 polarization is an essential step to wound healing
Revolutionizing Regenerative
Medicine for Humans & Animals
Pax Advanced Therapies is a pioneering company specializing in the development and distribution of innovative point-of-care autologous cell therapy systems for human and veterinary applications. These systems are designed to address tendon, ligament, muscle, and joint injuries, offering advanced regenerative solutions for human, equine, canine, and other veterinary patients.
MONOVET System Overview
MONOVET is a simple, single use disposable that concentrates PBMCs using a unique filter-based technology. As blood flows through the MONOVET system, peripheral blood mononuclear cells (PBMNC) are selectively captured on the surface of the filter and then back-flushed into a smaller volume, creating a PBMC concentrate.
Future Expansion to
Human Medicine
PAX Advanced Therapies is working to expand its groundbreaking mononuclear cell-based technologies into human medicine. This expansion will further enhance the potential of regenerative treatments and advance the field of cell therapy, offering new possibilities for medical innovations. Connect to learn in detail.
Meet The Founder Paxton
Paxton Provitera is an experienced biomedical engineer with a background in Physiology and Biophysics. He has spent over 15 years contributing to medical advancements, specializing in research and development.
About the Team
The team at PAX Advanced Therapies is composed of experienced professionals dedicated to advancing the field of cell therapy. We are committed to creating innovative solutions that address both veterinary and human medical needs.
Join Our Mailing List
© 2025, PAX Advanced Therapies. All Rights Reserved.